Regional campaigns: Improving local uptake while staying on-message

Dolan Desai|22nd October 2015




At Blue Latitude Health, our strategic planning, customer experience, and creative services teams work together to ensure that our clients’ campaigns launch without a hitch. We work across many different therapy areas, helping brands to position, launch, and support their campaigns at global, regional, and local levels. Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and healthcare systems can be so wildly variable and complicated.

A lot of work goes into a regional marketing strategy, but without coherent execution at the local level, the campaign loses impact. Account Director Dolan Desai talks us through the five core considerations that will allow you to maximise impact across a region through coherent execution:

1.  First and foremost, pin down your messaging

Before worrying about country-level assets, you must be crystal clear on what you want those assets to say. Not taking the time to establish and support the regional messaging before rolling out locally can lead to unfocussed and disjointed local activity. Once your messaging is clear, meaning you know what you want to say, and to whom, then you’re ready to move on to the next step: the messaging framework.  

 

Precision paediatrics: Treating patients with CAR-T

Guest Blogger|9th July 2019

Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking CAR-T therapy for the first patient in Europe, and how the centre of excellence has adapted to make precision medicine a reality

read more

What does it mean to be an agile organisation

Guest Blogger|27th June 2019

We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

read more

Battling breast cancer with precision medicine (Part 2)

Natasha Cowan|20th June 2019

Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives his side of the story and explains how industry can help oncologists treat more patients with targeted therapies.

read more